BBK Worldwide® Blog

BBK Worldwide is Joining the Publicis Health Network

Posted by BBK Worldwide on Tue, Jan 18, 2022

 

We are very excited to kick off the new year with the announcement that we have been acquired by Publicis Health, the healthcare communications leader that transforms healthcare marketing and communications into healthcare engagement.

Read the Press Release

 

Together, we share a commitment to the clinical trial experience and to enhancing understanding and access for all, and we look forward to joining the Publicis Health network. Our mission remains unchanged, as does our commitment to supporting you in advancing your clinical R&D efforts.

 

Read More

Topics: Most Viewed, Joan F. Bachenheimer, Publicis Health, Alexandra von Plato

COVID-19 Response Teaches Industry That Investing in Patient Partnership Is Key to All Research Endeavors

Posted by Joan F. Bachenheimer, Founding Principal, CEO on Thu, May 28, 2020

 

Rapid Adoption of Patient-centric Innovation Seen as Positive Outcome of COVID-19 Research Collaborations

While COVID-19 has severely affected many industries, scientific pursuit for a host of medical conditions is also threatened by sharply negative effects of the pandemic on clinical research for non-COVID-19-related pursuits. This is evidenced by an industry-reported 65 percent decline in new patient study enrollment in March 2020 relative to March 2019. The industry is adapting by borrowing from the zealous approach associated with COVID-19 research by deploying extraordinary collaboration and patient-centric services to achieve timelines for as many studies as possible.

Read More

Topics: Patient Centricity, Clinical Research, Clinical Trials, Clinical Trial Innovations, COVID-19, Joan F. Bachenheimer

Minimizing Clinical Trial Disruption from COVID-19

Posted by Elizabeth Gargill on Thu, Apr 2, 2020

BBK's Founding Principal and CEO Joan F. Bachenheimer discusses how BBK can help clinical trial sponsors respond to the immediate challenges resulting from the COVID-19 outbreak. 

Read More

Topics: Patient Engagement, Pharma15 Live!, Patient Enrollment, COVID-19, FDA Guidance, Coronavirus, Joan F. Bachenheimer